Will BioLine RX Ltd - ADR (BLRX) Stay at the Top of the Healthcare Sector?

A rating of 94 puts BioLine RX Ltd - ADR (BLRX) near the top of the Healthcare sector according to InvestorsObserver. BioLine RX Ltd - ADR's score of 94 means that it ranks higher than 94% of stocks in the sector. In addition, its overall score of 67 ranks it higher than 67% of all stocks.

BLRX has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on BLRX!

See Full BLRX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With BioLine RX Ltd - ADR Stock Today?

BioLine RX Ltd - ADR (BLRX) stock is trading at $1.47 as of 2:10 PM on Tuesday, Oct 17, a drop of -$0.08, or -5.16% from the previous closing price of $1.55. The stock has traded between $1.43 and $1.58 so far today. Volume today is below average. So far 803,688 shares have traded compared to average volume of 1,803,598 shares. Click Here to get the full Stock Report for BioLine RX Ltd - ADR stock.